Bottom line: Retatrutide looks incredibly powerful, but WITHOUT a long-term plan (that inclides nutrition, strength training, sleep, metabolism support and for some, suitable long term medication ), rebound is expected
In synovial macrophages, liraglutide treatment shifted cells from a pro-inflammatory M1 phenotype toward an anti-inflammatory M2 state, a transition that correlated with an overall reduction in inflammatory activity
Same time, same routine, every day
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved for treating type 2 diabetes and chronic weight management
MASLD affects 1 in 5 people in the UK but there are no medicines licensed to specifically treat the disease